Edesa Biotech Company Profile: Stock Performance & Earnings

Edesa Biotech Overview

Founded
2015

Status
Public

Employees
12

Stock Symbol
EDSA

Investments
1

Share Price
$7.70
(As of Friday Closing)

Edesa Biotech General Information

Description

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Contact Information

Website

www.edesabiotech.com

Ownership Status

Publicly Held

Financing Status

Corporation

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Stock Exchange

NAS

Primary Office

100 Spy Court
Markham, Ontario L3R 5H6
Canada

+1 (289) 000-0000





Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edesa Biotech Stock Performance

(As of Friday Closing)

Stock Price	Previous Close	52 wk Range	Market Cap	Shares	Average Volume	EPS
$7.70	$8.14	$4.05 - $12.00	$102M	13.3M	3.2M	-$1.05

Edesa Biotech Financials Summary

In Thousands, USD	TTM 30-Jun-2021	FY 2020 30-Sep-2020	FY 2019 30-Sep-2019	FY 2018 30-Sep-2018
EV	59,161	74,538	39,061	(3,874)
Revenue	1	329	411	212
EBITDA	(11,557)	(6,344)	(2,829)	(4,850)
Net Income	(11,672)	(6,364)	(2,777)	(5,039)
Total Assets	16,877	10,762	5,718	11,780
Total Debt	121	164	0

Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edesa Biotech Valuation & Funding

Deal Type	Date	Amount	Valuation/ EBITDA	Post-Val	Status	Debt

This information is available in the PitchBook Platform. To explore Edesa Biotech‘s full profile, request access.

Request a free trial

Edesa Biotech Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in expl

Drug Discovery

Markham, Canada

12 As of 2020

000.00

00000000 000.00

000000 0

im veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis a

000000000000000

Cranford, NJ

00 As of 0000

000.00

000000000 000.00

0000000

ing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam

000000000000000

Wayne, PA

00 As of 0000

00000

00000000000 00000

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edesa Biotech Competitors (2)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Citius Pharma	Formerly Angel backed	Cranford, NJ	00	000.00	000000000	000.00
0000000 0000000000	Formerly VC-backed	Wayne, PA	00	00000	00000000000	00000

You’re viewing 2 of 2 competitors. Get the full list »

Edesa Biotech Executive Team (5)

Name	Title	Board Seat	Contact Info
Par Nijhawan MD	Founder, Chief Executive Officer, Secretary & Board Director
Michael Brooks Ph.D	President
Gary Koppenjan	Vice President, Investor Relations and Communications
Kathi Niffenegger	Chief Financial Officer, Finance & Chief Accounting Officer, Accounting

You’re viewing 4 of 5 executive team members. Get the full list »

Edesa Biotech Board Members (8)

Name	Representing	Role
Carlo Sistilli	Edesa Biotech	Board Member
Frank Oakes	Self	Board Member
Lorin Johnson Ph.D	Self	Board Member
Par Nijhawan MD	Edesa Biotech	Founder, Chief Executive Officer, Secretary & Board Director
Paul William Pay	Edesa Biotech	Board Director